Exposure to Proton Pump Inhibitors and the Risk of Incident Asthma in Patients with Coronary Artery Diseases: A Population-Based Cohort Study

Exposure to Proton Pump Inhibitors and the Risk of Incident Asthma in Patients with Coronary Artery Diseases: A Population-Based Cohort Study

We aimed to determine the association between proton pump inhibitor (PPI) use and incident asthma in patients with coronary artery disease (CAD). This nationwide cohort study collected claims data from the Taiwanese Bureau of National Health Insurance from 2004 to 2013. The primary outcome, i.e., th...

Full description

Bibliographic Details
Main Authors:	Tsung-Kun Lin, Chin-Feng Tsai, Jing-Yang Huang, Lung-Fa Pan, Gwo-Ping Jong
Format:	Article
Language:	English
Published:	MDPI AG 2022-05-01
Series:	Journal of Personalized Medicine
Subjects:	proton pump inhibitors coronary artery disease asthma peptic ulcer disease
Online Access:	https://www.mdpi.com/2075-4426/12/5/824

Similar Items

Comparison of Oral versus Intravenous Proton Pump Inhibitors in Preventing Re-bleeding from Peptic Ulcer after Successful Endoscopic Therapy
by: Seyed Mohammad Valizadeh Toosi, et al.
Published: (2018-10-01)

Comparative characteristics of proton pump inhibitor effectiveness in the treatment of gastric ulcer and duodenal ulcer
by: Balitska Olesya P., et al.
Published: (2020-06-01)

Oral versus intravenous proton pump inhibitors in preventing re-bleeding for patients with peptic ulcer bleeding after successful endoscopic therapy
by: Yen Hsu-Heng, et al.
Published: (2012-06-01)

Comparing proton pump inhibitors with histamin-2 receptor blockers regarding the risk of osteoporotic fractures: a nested case-control study of more than 350,000 Korean patients with GERD and peptic ulcer disease
by: Joo-Hyun Park, et al.
Published: (2020-10-01)

Pharmacological Treatment for Peptic Ulcer Bleeding
by: Dae Won Ma, et al.
Published: (2018-12-01)

Asthma and the risk of gastrointestinal disorders: a Mendelian randomization study
by: Dennis Freuer, et al.
Published: (2022-03-01)

INAPPROPRIATE USAGE OF INTRAVENOUS PROTON PUMP INHIBITORS AND ASSOCIATED FACTORS IN A HIGH COMPLEXITY HOSPITAL IN BRAZIL
by: Laura M BISCHOFF, et al.
Published: (2021-04-01)

Conservative Management of Asymptomatic Pneumoperitoneum; Report of Two Cases
by: Leila Alizadeh, et al.
Published: (2019-01-01)

An extended 36-week oral esomeprazole improved long-term recurrent peptic ulcer bleeding in patients at high risk of rebleeding
by: Hsueh-Chien Chiang, et al.
Published: (2022-10-01)

Diagnosis and Treatment of Peptic Ulcer in Adults (Clinical Guidelines of the Russian Gastroenterological Association, Russian Society of Colorectal Surgeons and the Russian Endoscopic Society)
by: V. T. Ivashkin, et al.
Published: (2020-04-01)

Current Trends in Treatment for Acid-Dependent Diseases: Clinical Efficacy and Safety of Rabeprazole
by: O. D. Lopina, et al.
Published: (2021-12-01)

Modern approaches to the treatment of peptic ulcer disease and prospects for the use of biological therapy
by: I. V. Koshurba, et al.
Published: (2023-06-01)

Gastric pain
by: Natalie Schellack, et al.
Published: (2015-09-01)

Hematologic and laboratory parameters in patientis with peptic ulcer bleeding treated by two modalities of endoscopic haemostasis and proton pompe inhibitors
by: Amila Mehmedović-Redžepović, et al.
Published: (2011-02-01)

Proton pump inhibitors overuse - consequences among patients
by: Patrycja Kmiotek, et al.
Published: (2019-08-01)

Proton pump inhibitors overuse - consequences among patients
by: Patrycja Kmiotek, et al.
Published: (2019-08-01)

Effect of proton pump inhibitors on platelet inhibition activity of clopidogrel in Chinese patients with percutaneous coronary intervention
by: Kwan T, et al.
Published: (2011-06-01)

Inhibidores de la bomba de protones por vía intravenosa en la hemorragia por úlcera péptica: ¿es necesaria la supresión ácida máxima para disminuir el resangrado? Intravenous proton-pump for acute peptic ulcer bleeding: is profound acid supression beneficial to reduce the risk of rebleeding?
by: A. Garrido, et al.
Published: (2008-08-01)

A real-world retrospective study of omeprazole–domperidone combination in managing acid peptic disease with PRoton-pump Inhibitors in patients with type 2 DiabEtes mellitus (PRIDE-2)
by: Bharat Saboo, et al.
Published: (2023-02-01)

Usage of intravenous forms of proton pump inhibitors
by: Marijan Ivanuša
Published: (2006-12-01)

Chronic Asthma and Gastro-Esophageal Reﬂux Disease: The Treatment Plans
by: Leila Ghofraniha, et al.
Published: (2015-09-01)

Influence of vitamin B12 on homocysteine level in patients with comorbid course of coronary heart disease and gastrointestinal acid-related diseases
by: V. F. Orlovskiy, et al.
Published: (2012-12-01)

Prophylactic Gastric Histopathological Evaluation of Fluvoxamine and Mirtazapine in Aspirin Induced Rat Model
by: Shahnaz Fatima, et al.
Published: (2020-12-01)

Hemorragia del tracto digestivo superior, enfoque para el médico general
by: Alejandro Rendón Porras, et al.
Published: (2022-03-01)

Intravenous non-high-dose pantoprazole is equally effective as high-dose pantoprazole in preventing rebleeding among low risk patients with a bleeding peptic ulcer after initial endoscopic hemostasis
by: Liang Chih-Ming, et al.
Published: (2012-03-01)

Regular proton pump inhibitor use and incident dementia: population-based cohort study
by: Peidong Zhang, et al.
Published: (2022-09-01)

Incidence of hypomagnesemia on proton pump inhibitors at the Huntington Veterans Affairs Medical Center – IHOP
by: Ebrahim Sabbagh, et al.
Published: (2016-07-01)

Intermittent concurrent use of clopidogrel and proton pump inhibitors did not increase risk of adverse clinical outcomes in Chinese patients with coronary artery disease
by: Wanbing He, et al.
Published: (2021-02-01)

Inadequate response to proton pump inhibitor therapy: Causes and patient management tactics
by: Iu V Evsiutina, et al.
Published: (2015-02-01)

Proton Pump Inhibitors in the Management of Tachypnoea following Panproctocolectomy: A Case of High Output Ileostomy
by: Neville Azzopardi, et al.
Published: (2011-04-01)

Outcome of Post Esophageal Variceal Band Ligation with Sucralfate and Proton Pump Inhibitor vs. Proton Pump Inhibitor Alone in Cirrhotic Patients
by: Binod Karki, et al.
Published: (2019-12-01)

Proton Pump Inhibitors: How Safe is Long Usage of Pantoprazole?
by: Yu.M. Stepanov, et al.
Published: (2013-09-01)

Association Between Proton Pump Inhibitors and Asthma: A Population-Based Cohort Study
by: Yao-Tung Wang, et al.
Published: (2020-05-01)

Meniere’s disease and the use of proton pump inhibitors
by: A Pirodda, et al.
Published: (2010-09-01)

A dual role of proton pump inhibition on cancer: a critical review
by: Edizer Deniz Tuna, et al.
Published: (2023-02-01)

Efficacy and safety of concomitant use of proton pump inhibitors with aspirin-clopidogrel dual antiplatelet therapy in coronary heart disease: A systematic review and meta-analysis
by: Xiaofeng Luo, et al.
Published: (2023-01-01)

Proton-pump inhibitors
by: Vasudevan G. Naidoo
Published: (2015-05-01)

Efficacy and safety of proton pump inhibitors combined with clopidogrel in patients undergoing percutaneous coronary intervention: a meta-analysis
by: Yao-Yao Han, et al.
Published: (2021-03-01)

SPECTRUM OF CULTURE POSITIVE HOSPITAL ACQUIRED PNEUMONIA IN PATIENTS RECEIVING PROTON PUMP INHIBITORS
by: Aaqib Jahangir Khan, et al.
Published: (2018-10-01)

Evaluation of risk factors for perforated peptic ulcer
by: Kazuki Yamamoto, et al.
Published: (2018-02-01)